Contact Information

Center for Neurovisceral Sciences & Women's Health
11301 Wilshire Boulevard
Building 115, Room 223
Los Angeles, CA 90073
On-campus mail: 38-154 NPI 175919 or BVA Bldg. 115, Room 223 179247
Tel: (310) 206-6657
Fax: (310) 794-2864
E-mail: sberman@ucla.edu
Web: www.cure.med.ucla.edu, www.uclacns.org, www.uclamindbody.org

Biosketch

Dr. Berman has been at UCLA for the past 12 years. He has made contributions to the psychophysiology of substance abuse vulnerability, developmental cognitive electrophysiology, and brain imaging of functional gastrointestinal disorders. He is currently co-Principal Investigator of an National Institute on Alcohol Abuse and Alcoholism study of electrophysiological, neuropsychological, personality and genetic risk factors in children of alcoholics. Dr. Berman is head of neuroimaging for the UCLA Center for Neurovisceral Sciences and Women's Health.

Selected References

Berman S, Noble E. D2 dopamine receptor (DRD2) gene and family stress: interactive effects on cognitive function in children. Behavior Genetics. 1997; 27: 33-43.

Berman S, Munakata J, Naliboff B, Chang L, Mandelkern M, Silverman D, Kovalik E, Mayer E. Gender differences in regional brain responses to visceral pressure in IBS patients. European Journal of Pain. 2000; 4:157-172.

Berman SM, Chang L, Suyenobu B, Derbyshire S, Stains J, FitzGerald L, Mandelkern M, Hamm L, Naliboff B, Mayer EA. Condition-specific deactivation of brain regions by 5-HT3 receptor antagonist Alosetron. Gastroenterology. 2002. In press.